Page 41 - IMO-2-2

Innovative Medicines & Omics Herbal remedies for diabetes mellitus

doi: 10.3390/nu12030872 2022;14(13):2773.
77. Przeor M. Some common medicinal plants with antidiabetic doi: 10.3390/nu14132773
activity, known and available in Europe (a mini-review). 85. Park HJ, Kim DH, Park SJ, Kim JM, Ryu JH. Ginseng
Pharmaceuticals. 2022;15(1):65.
in traditional herbal prescriptions. J Ginseng Res.
doi: 10.3390/ph15010065 2012;36(3):225-241.
78. Jiao Y, Wang X, Jiang X, Kong F, Wang S, Yan C. Antidiabetic doi: 10.5142/jgr.2012.36.3.225
effects of Morus alba fruit polysaccharides on high-fat
diet-and streptozotocin-induced type 2 diabetes in rats. 86. Jeon WJ, Oh JS, Park MS, Ji GE. Anti‐hyperglycemic effect
J Ethnopharmacol. 2017;199:119-127. of fermented ginseng in type 2 diabetes mellitus mouse
model. Phyther Res. 2013;27(2):166-172.
doi: 10.1016/j.jep.2017.02.003.
doi: 10.1002/ptr.4706
79. Ali BH, Blunden G, Tanira MO, Nemmar A. Some
phytochemical, pharmacological and toxicological 87. Kumar S, Brooks MS. Use of red beet (Beta vulgaris L.) for
properties of ginger (Zingiber officinale Roscoe): A review of antimicrobial applications-a critical review. Food Bioprocess
recent research. Food Chem Toxicol. 2008;46(2):409-420. Technol. 2018;11(1):17-42.
doi: 10.1016/j.fct.2007.09.085 doi: 10.1007/s11947-017-1942-z
80. Rani MP, Krishna MS, Padmakumari KP, Raghu KG, 88. Cherrada N, Elkhalifa Chemsa A, Gheraissa N, et al.
Sundaresan A. Zingiber officinale extract exhibits antidiabetic Antidiabetic medicinal plants from the Chenopodiaceae
potential via modulating glucose uptake, protein glycation family: A comprehensive overview. Int J Food
and inhibiting adipocyte differentiation: An in vitro study. Prop. 2024;27(1):194-213.
J Sci Food Agric. 2012;92(9):1948-1955.
doi: 10.1080/10942912.2023.2301576
doi: 10.1002/jsfa.5567
89. Abd El-Ghffar EA, Hegazi NM, Saad HH, et al. HPLC-
81. Akash MS, Rehman K, Tariq M, Chen S. Zingiber officinale ESI-MS/MS analysis of beet (Beta vulgaris) leaves and
and type 2 diabetes mellitus: Evidence from experimental its beneficial properties in type 1 diabetic rats. Biomed
studies. Crit Rev Eukaryot Gene Expr. 2015;25(2):90-112.
Pharmacother. 2019;120:109541.
doi: 10.1615/critreveukaryotgeneexpr.2015013358
doi: 10.1016/j.biopha.2019.109541
82. Hasimun P, Adnyana IK. Zingiberaceae family effects
on alpha-glucosidase activity: Implication for diabetes. 90. Kasali FM, Tusiimire J, Kadima JN, Agaba AG. Ethnomedical
In: Bioactive Food as Dietary Interventions for Diabetes. uses, chemical constituents, and evidence-based
Netherlands: Elsevier; 2019. p. 387-393. pharmacological properties of Chenopodium ambrosioides
L.: extensive overview. Futur J Pharm Sci. 2021;7(1):153.
83. Momtaz S, Hassani S, Khan F, Ziaee M, Abdollahi M.
Cinnamon, a promising prospect towards Alzheimer’s doi: 10.1186/s43094-021-00306-3
disease. Pharmacol Res. 2018;130:241-258. 91. Kasali FM, Kadima JN, Tusiimire J, Ajayi CO, Agaba
doi: 10.1016/j.phrs.2017.12.011 AG. Effects of the oral administration of aqueous and
methanolic leaf extracts of Chenopodium ambrosioides
84. Silva ML, Bernardo MA, Singh J, de Mesquita MF. Cinnamon L.(Amaranthaceae) on blood glucose levels in Wistar rats.
as a complementary therapeutic approach for dysglycemia
and dyslipidemia control in type 2 diabetes mellitus and J Exp Pharmacol. 2022;14:139-148.
its molecular mechanism of action: A review. Nutrients. doi: 10.2147/JEP.S356564

Volume 2 Issue 2 (2025) 35 doi: 10.36922/imo.7520